When should potentially false research findings be considered acceptable?

by Benjamin Djulbegovic, Iztok Hozo
Published 2007-02-01

Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.

by Athanasios Tsalatsanis, Iztok Hozo, Ambuj Kumar, Benjamin Djulbegovic
Published 2015-01-01

A social network analysis of treatment discoveries in cancer.

by Athanasios Tsalatsanis, Laura Barnes, Iztok Hozo, John Skvoretz, Benjamin Djulbegovic
Published 2011-03-01

The predicament of patients with suspected Ebola

by Thomas Mayrhofer, Robert M Hamm, Jef Van den Ende, Iztok Hozo, Benjamin Djulbegovic
Published 2017-07-01

Genetic Association of Peptidoglycan Recognition Protein Variants with Inflammatory Bowel Disease.

by Fareeha Zulfiqar, Iztok Hozo, Sneha Rangarajan, Roy A Mariuzza, Roman Dziarski, Dipika Gupta
Published 2013-01-01

Elective induction of labor at 39 weeks among nulliparous women: The impact on maternal and neonatal risk.

by Rachel G Sinkey, Jasmin Lacevic, Tea Reljic, Iztok Hozo, Kelly S Gibson, Anthony O Odibo, Benjamin Djulbegovic, Charles J Lockwood
Published 2018-01-01

Peptidoglycan recognition proteins kill bacteria by inducing oxidative, thiol, and metal stress.

by Des Raj Kashyap, Annemarie Rompca, Ahmed Gaballa, John D Helmann, Jefferson Chan, Christopher J Chang, Iztok Hozo, Dipika Gupta, Roman Dziarski
Published 2014-07-01

Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.

by Benjamin Djulbegovic, Ambuj Kumar, Branko Miladinovic, Tea Reljic, Sanja Galeb, Asmita Mhaskar, Rahul Mhaskar, Iztok Hozo, Dongsheng Tu, Heather A Stanton, Christopher M Booth, Ralph M Meyer
Published 2013-01-01